Neiraxin (Thiamine Hydrochloride, Cyanocobalamin, Pyridoxine Hydrochloride, Lidocaine Hydrochloride)

Each vitamin component serves as a co‑factor in essential metabolic pathways: thiamine supports carbohydrate metabolism, cyanocobalamin is required for DNA synthesis and neurologic health, and pyridoxine participates in amino‑acid and neurotransmitter synthesis. Lidocaine, the anesthetic part, blocks voltage‑gated sodium channels, preventing nerve impulse transmission and producing temporary pain relief at the injection site.

The specific dose and frequency of Neiraxin are determined by the prescribing clinician based on the patient’s vitamin status, clinical condition and procedural needs. Healthcare professionals should follow local prescribing guidelines and adjust the regimen according to individual therapeutic response and safety considerations.

Safety data for Neiraxin in pregnancy and lactation are limited. The decision to use the product should be made by a qualified healthcare provider after weighing potential benefits against possible risks to the mother and fetus or infant. Generally, B‑vitamin supplementation may be indicated in deficiency, but lidocaine exposure should be evaluated carefully.

To place an order, submit an enquiry on the Neiraxin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Neiraxin uniquely combines three B‑vitamins with a local anesthetic in a single intramuscular formulation, offering both deficiency correction and procedural analgesia. Other vitamin‑B injections typically contain only one or two vitamins and lack an anesthetic component, so they do not provide the same immediate pain‑relief benefit during intramuscular procedures.

Neiraxin should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze the solution, and inspect the vial for particulate matter before administration.

Neiraxin is administered by a qualified healthcare professional via intramuscular injection. The injection site should be prepared with aseptic technique, and the recommended volume is injected slowly to minimise discomfort. The exact injection site and volume depend on the clinical indication and patient characteristics.

The most serious risks include severe allergic reactions such as anaphylaxis, cardiovascular collapse or arrhythmias due to lidocaine toxicity, and rare cases of severe skin reactions like Stevens‑Johnson syndrome. Prompt recognition and emergency management are essential if any of these events occur.

Neiraxin should be avoided in individuals with a known hypersensitivity to any of its components, especially lidocaine. Patients with severe cardiac conduction disorders, uncontrolled hypotension, or those receiving high‑dose vitamin B supplementation without medical supervision should also be evaluated carefully before use.